This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Jayakumar also spoke about the detailed procedures and SOPs needed for investigating market complaints and how these systems should be integrated into a companys overall quality management system.
Companies are investing heavily in digital tools to streamline communication and build stronger connections. Strategies like storytelling, personalized educational content, and two-way communication channels create trust and build loyalty. Patient-Centric Marketing Patients want to feel heard.
The impact of packaging is felt only when it does not do its job and therefore pharmaceuticalcompanies have traditionally invested quite a bit on product packs, also using them as part of their branding strategy. sq mm of material – there is more than 20 per cent reduction of packaging material. per cent CAGR.
Manufacturing Dependencies and Global Disruption Pharmaceutical manufacturing doesn’t operate within national borders. From packaging to proprietary coatings to the APIs themselves, nearly every prescription bottle represents a mosaic of global logistics. Even American-made branded drugs rely heavily on foreign-sourced components.
Large pharmaceuticalcompanies such as AbbVie, Lilly, Roche and Takeda have demonstrated strong interest in licensing innovator oligonucleotides for CNS indications, accounting for 63% of licensing deals between 2021 and 2025 year-to-date. ASOs accounted for more than half ($3.54 billion), while siRNAs made up more than a third ($2.51
Developed by US biotech ARS Pharmaceuticals and under exclusive license in the UK by Danish pharmaceuticalcompany ALK-Abelló, the single-dose nasal spray is indicated for use in adults and children weighing over 30kg and delivers its entire contents (2mg) upon activation. How will RFK Jr’s American dream for vaccines play out?
The initiative comes at a crucial time, as British pharmaceuticalcompanies are significantly increasing their investments in the United States. How will RFK Jr’s American dream for vaccines play out? GSK invested $800m in drug substance and drug product manufacturing facilities in the US in October 2024.
More specifically, the Indian Pharmaceutical Alliance, an organisation representing the country’s largest pharmaceuticalcompanies, has urged the government to reduce import tariffs from the current 10% to zero for pharmaceutical imports from the US. Give your business an edge with our leading industry insights.
Zentiva Group has entered into a licence and supply agreement with pharmaceuticalcompany Lupin for the commercialisation of the latter’s biosimilar Certolizumab Pegol, a tumour necrosis factor alpha (TNFα) inhibitor medicine, across several markets. How will RFK Jr’s American dream for vaccines play out? Credit: Zentiva Group, a.s.
This report looks at marketed therapies and their sales projections, pipeline drug trends, and key development challenges for pharmaceuticalcompanies, as well as the role of CDMOs in targeted modality development and what to look for in a development and manufacturing partner. How will RFK Jr’s American dream for vaccines play out?
Miranda McLaren June 30, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook When Donald Trump was elected the 47 th president of the United States of America, the outlook for pharmaceuticals was unclear, with 55% of North American industry professionals expecting negative repercussions when surveyed by GlobalData later that month.
The government therefore is advocating for the creation of the new drug regulatory agency to expedite economic growth, streamline drug approvals and attract international pharmaceuticalcompanies to invest in the country. How will RFK Jr’s American dream for vaccines play out?
Katarina Zahedi, pharma analyst at GlobalData, comments: “These investments reflect a growing trend among pharmaceuticalcompanies to bolster domestic operations in response to geopolitical pressures and potential tariffs on imported pharmaceuticals.” Give your business an edge with our leading industry insights.
In one of the fierier remarks from the roundtable, RFK Jr said: “At every level, doctors, other providers, our hospitals, the pharmaceuticalcompanies, the insurance companies, all make money by keeping us sick. We may still continue to send you service-related and other non-promotional communications.
It feels like in the US, pharmaceuticalcompanies are capitalising on people’s frustration and desperation to lose weight.” Novo Nordisk took a different route with Hims & Hers – the drugmaker partnered with the telehealth company to offer Wegovy via a bundled membership package in April 2025.
EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Early collaborations Several pharmaceuticalcompanies have begun exploring quantum computing through research partnerships and pilot projects.
The Digital Transformation of Patient Marketing Technology has revolutionized how pharma communicates with patients. Additionally, integrating offline and online experiencessuch as QR codes on packaging leading to mobile resourcesenhances the continuity of care. FAQs What is patient marketing in pharma?
He noted that these conflicts of interest continue to the current day, with ACIP members receiving substantial funding from pharmaceuticalcompanies. The health secretary pointed to historical evidence for this, including an investigation from over 20 years ago. Give your business an edge with our leading industry insights.
Communication between European Union (EU) member states is ongoing to finalise the details of the legislation, but at its core, the EHDS will provide a single registry of patient data from across the continent. Trust is something that you earn, so how we communicate what’s coming out of this directive is very important.
By GlobalData Learn more about Strategic Intelligence In light of the approvals of Leqembi and Kisunla, large pharmaceuticalcompanies are increasingly investing in Alzheimer’s disease through high-value acquisitions. Stay proactive with real-time data and expert analysis.
Vaccine R&D stagnation likely Although ACIP recommendations are separate from the US Food and Drug Administration (FDA)’s approvals, national immunisation recommendation provides a key pillar on which to guide pipeline development for a pharmaceuticalcompany. Give your business an edge with our leading industry insights.
Indeed, a key aspect of EU GMP Annex 1 is the requirement for pharmaceutical manufacturers to develop a comprehensive Contamination Control Strategy (CCS) that documents their approach to assuring the sterile drug product’s high quality and, therefore, enhancing patient safety. Register your details to read more The post How ready are you?
The overarching principle set out in Codes of Practice, and in particular the Principles for the use of digital channels in the EFPIA Code , is that the legislation and Codes of Practice apply equally to communications by companies on social media and digital channels. What are the key points from the Guidance?
Navigating these regulatory challenges is essential to ensure compliance, maintain trust, and effectively communicate the benefits and risks of pharmaceutical products. In this blog post, we will explore best practices for pharmaceuticalcompanies to navigate the complex landscape of regulatory challenges in marketing.
Pharmaceuticalcompanies need to be prepared to answer the call for increased demand and supply into new markets, ensuring the proper resources and logistics framework are in place. While using high-capacity aircraft and minimal packaging reduces weight and increases capacity for vital products by using fewer flights.
In an era where medicine is rapidly becoming more personalized, why do pharmaceuticalcompanies still struggle to effectively engage with the very individuals they aim to serve? Additionally, the COVID-19 pandemic has intensified public scrutiny of pharmaceuticalcompanies, creating a unique opportunity to build trust with patients.
Navigating these regulatory challenges is essential to ensure compliance, maintain trust, and effectively communicate the benefits and risks of pharmaceutical products. In this blog post, we will explore best practices for pharmaceuticalcompanies to navigate the complex landscape of regulatory challenges in marketing.
It can be used for sales, marketing and patient communication materials, in print or digital form. Tag partners with pharmaceuticalcompanies to help them effectively communicate with HCPs and patients, by increasing marketing efficiency, driving speed-to-market and delivering launch and regulatory excellence.
Documentation : Keeping detailed records of orders, specifications, manufacturing processes, packaging, and labeling to ensure traceability and compliance. Packaging and labeling operations for investigational products are often complex and must meet specific requirements to ensure the integrity of clinical trials.
Pharmaceuticalcompanies are putting their trust in the immense potential this new generation of medicine has for treating individuals with rare genetic diseases, which currently affect an estimated 280 million patients worldwide. Products are stored and packaged in a dedicated suite by a dedicated team,” explains MacNeir.
From clear communication with an unsettled, dispersed workforce to maintaining positive energy and managing people’s working hours, the need for open, inclusive and empathetic leadership has never been more important. . iii] It’s no longer just about the company, compensation package and secondary benefits (e.g.,
“A lot of printed materials have been migrated to digital so that patients can opt-in to receive digital communications or HCPs can receive digital product or disease state information in the form of rep-triggered emails and microsites. Joanna Carlish. The idea is about really tapping into where the customer is in their journey.
7 Access to digital communications also remains a challenge in some Member States especially for those groups at risk of poverty and social exclusion (7.6 The responsibility of printing paper leaflets is currently a key regulatory obligation for pharmaceuticalcompanies.
When they clearly understand a product, they are more likely to trust the pharmaceuticalcompany and choose its drugs for prescriptions over those from competitors they do not fully comprehend. Improved retention How do pharma companies stay top of mind? IVAs make it easier to communicate ideas between these key stakeholders.
Specifically, she engaged with several important stakeholders and received valuable information about future sales and marketing strategies, decision-making vision, and innovation trends among Chinese pharmaceuticalcompanies.
Container Closure Integrity Testing (CCIT) is used to evaluate the ability of a pharmaceutical’s primary packaging to protect the sterility of its contents. On a regular basis, pharmaceutical manufacturers are performing CCIT during commercial production to ensure that packaging processes are operating as they should.
manufacturing, packaging, testing, storage and/or distribution of products) shall be validated to provide assurance that their system is capable of producing without error and that the results are robust and reproducible.” Category 1: Operating Systems Category 2: Firmware (e.g. What is the validation lifecycle?
Competitive Analysis: Evaluating the market share and brand presence of established pharmaceuticalcompanies and generic drug manufacturers. Communicating the value proposition through various channels such as physician detailing, patient education materials, and digital marketing campaigns.
Compared to other dosage forms, tablets are simpler to manufacture, package, and transport. As with any pharmaceutical manufacturing, challenges can be many, and processes are highly regulated. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
By implementing robust validation protocols, pharmaceuticalcompanies can ensure that their products are safe, effective, pure and of the highest quality. A scenario where validation is required The management of your company has recently decided to install an information management system in analytical laboratory.
They can also give their feedback on the design of the clinical trial, if the comparator reflects the standard of care, and if real-world evidence is part of the evidence requirement package.” Overall, it is never too soon to begin market access activities, but it can easily be too late. Please check your email to download the Case Study.
Examples include oil leaks from equipment in a packaging line or small solvent spills in the printing and labeling machine. – Communicating the location of the spill kit to all staff in the area. – All materials used in the clean-up activities have been packaged for appropriate disposal or have been cleaned and returned.
To combat such challenges, pharmaceuticalcompanies need to adopt processes that are not just efficient, but agile. Empowering labs with automated equipment that produces rich, traceable, and actionable data insights means pharmaceuticalcompanies can ensure drug production runs smoothly – even under stress.
This really tested pharmaceuticalcompanies,” explains Ki-Sung. We found that strong and open channels of communication were imperative. The company remained in close and frequent communication with regulatory agencies to accelerate procedures for the evaluation and authorisation of the clinical trials.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content